The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Drynol 10 mg orodispersible tablet

10 milligram(s) Orodispersible tablet

Menarini International Operations Luxembourg S.A.PA0865/018/002

Main Information

Trade NameDrynol 10 mg orodispersible tablet
Active SubstancesBilastine
Strength10 milligram(s)
Dosage FormOrodispersible tablet
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberPA0865/018/002

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX29 bilastine

Status

Authorised/WithdrawnAuthorised
Licence Issued14/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back